您当前的位置:
首页 >
文章列表页 >
Mechanism of Dahuang Zhechongwan in Inhibiting Silicosis in Mice via p38 MAPK/NF-κB/TGF-β1 Pathway
Pharmacology | 更新时间:2021-05-17
    • Mechanism of Dahuang Zhechongwan in Inhibiting Silicosis in Mice via p38 MAPK/NF-κB/TGF-β1 Pathway

    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 27, Issue 11, Pages: 27-34(2021)
    • DOI:10.13422/j.cnki.syfjx.20211190    

      CLC: R2-0;R22;R285.5;R289
    • Received:22 January 2021

      Published Online:30 March 2021

      Published:05 June 2021

    移动端阅览

  • WU Li-juan,HE Xiao-yan,LIANG Jing-tao,et al.Mechanism of Dahuang Zhechongwan in Inhibiting Silicosis in Mice via p38 MAPK/NF-κB/TGF-β1 Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(11):27-34. DOI: 10.13422/j.cnki.syfjx.20211190.

  •  
  •  

0

Views

16

下载量

7

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Mechanism of Dahuang Zhechongwan in Inhibiting Renal Fibrosis in Rats by Regulating Intestinal Flora Based on 16S rDNA Sequencing
Mechanism of Dahuang Zhechongwan in Treating Myocardial Fibrosis of Rats via TGF-β1/Smads/miR29 Pathway
Mechanism of Dahuang Zhechongwan Against Multiple Organ Fibrosis: A Review

Related Author

WU Lijuan
XIAO Jingyi
GU Zhengzheng
HUANG Jing
LI Xin
HE Xiaoyan
WANG Yao
LIANG Jingtao

Related Institution

Hospital of Chengdu University of Traditional Chinese Medicine (TCM)
School of Public Health, Chengdu University of TCM
Chengdu Qingyang District Funan Jinsha Community Health Service Center
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine(TCM)
Chengdu University of TCM
0